Search results
Results from the WOW.Com Content Network
The journal covers research on the controlled release and delivery of drugs and other biologically active agents. Announcements and reports of future meetings pertaining to the activities of the Controlled Release Society are also included. According to the Journal Citation Reports, the journal has a 2022 impact factor of 10.8, ranking it 10th ...
Advanced Drug Delivery Reviews is a peer-reviewed medical journal covering research involving the controlled release and delivery of drugs and other biologically active agents. [1] The editor-in-chief is H. Ghandehari.
Since the approval of the first controlled-release formulation in the 1950s, research into new delivery systems has been progressing, as opposed to new drug development which has been declining. [13] [14] [15] Several factors may be contributing to this shift in focus. One of the driving factors is the high cost of developing new drugs.
The U.S. Centers for Disease Control and Prevention is seeking to withdraw all papers involving its researchers that are being considered for publication by external scientific journals to allow ...
International Journal of Pharma and Bio Sciences; International Journal of Pharmaceutics; Journal of Biomedical Nanotechnology; The Journal of Clinical Pharmacology; Journal of Controlled Release; Journal of Ethnopharmacology; Journal of Generic Medicines; Journal of Microencapsulation; Journal of Oncology Pharmacy Practice; Journal of Pharmacy ...
Controlled and large-scale studies are lacking, but a 2022 study from the International Journal of Circumpolar Health did find increasing scientific support for the health benefits of cold water ...
The science of controlled release developed further with more oral sustained-release products in the late 1940s and early 1950s, the development of controlled release of marine anti-foulants in the 1950s, and controlled release fertilizer in the 1970s where sustained and controlled delivery of nutrients was achieved following a single ...
A reescalating battle between pharmaceutical companies and pharmacy benefit managers is brewing in Washington, D.C., as President Donald Trump's new administration takes shape. The drug industry's ...